Microdosing continues to capture headlines and the imagination of researchers, the curious, and many people searching for relief from difficult—sometimes lifelong—mental health challenges. Yet research on the effectiveness of small, capsule-sized doses of psychedelic compounds for conditions such as depression, anxiety, and chronic pain is still relatively limited. Despite encouraging findings and the testimony of many people, myself included, much uncertainty remains.
I’ve been microdosing for the last several years, and my own experience falls somewhere between that of a champion and a skeptic. I’ve seen firsthand how microdosing, particularly when approached as one tool among many in a broader mental health and wellness journey rather than as a quick solution, can be life-changing.
At the same time, I’ve also seen people who found little or no benefit. That mixed experience has contributed to understandable skepticism and to suggestions that those who improve may simply be experiencing a powerful placebo effect.
Personally, I think microdoses work—but perhaps not in the way they’re commonly described. I often caution people who are interested in microdosing that approaching it as though a small dose of psilocybin cures chronic depression the way an aspirin relieves a headache may set them up for disappointment.
Instead, I think microdosing can temporarily increase our sensitivity to emotions that have become difficult to access because of grief, trauma, chronic stress, or simply the pace of everyday life. I sometimes imagine those emotions sitting behind a dam. For a brief period after a microdose, that dam may become just porous enough to allow a few small streams of long-contained emotional material to reach consciousness in a way that feels manageable rather than overwhelming.
If that’s true, an interesting question follows. What happens if we intentionally use that window of awareness to meet those emotions with curiosity and presence? Could gradually processing what has been held back begin to change our relationship with ourselves? And if enough of that emotional material were eventually integrated, what else might become possible?
As you might guess, while there may be other benefits—some of which I’ll explore throughout this guide—emotional processing and emotional regulation remain at the center of why I continue the practice. That perspective will shape much of what follows.
The perspective you’ll encounter throughout this guide grows out of several years of personal experience working with natural medicines, cultivating mushrooms for personal use in Colorado in accordance with state and local law, and conversations with clients, many of whom have shared meaningful positive outcomes.
Whenever the research can answer a question, I’ll begin there. When it can’t, I’ll clearly distinguish scientific evidence from my own observations and experience.
What exactly is a “microdose”?
For researchers and practitioners alike, microdosing usually means taking a small fraction of a full psychedelic dose on a repeated schedule (or protocol) that allows someone to remain able to carry out ordinary activities.
It’s important to recognize that there is no universally agreed-upon standard for microdosing. Not unlike regular microdosers, researchers often study different substances, dose amounts, schedules, treatment protocols, outcome measures, and even have widely varying definitions of what constitutes a microdose. As Polito and Liknaitzky observe in their review of the literature, this lack of consistency makes it difficult to compare findings across studies.
For the purposes of this guide, I’ll stick to what I know best and focus on psilocybin derived from Psilocybe cubensis and Psilocybe natalensis mushrooms, generally using milder varieties that I cultivate in Colorado for personal use and sharing in accordance with state and local laws.
What a microdose feels like and how it works
A longstanding debate among people who microdose is whether you should feel anything at all.
Some practitioners believe a microdose should be completely sub-perceptual—small enough that you wouldn’t notice any immediate effects. Personally, I think it depends on your goals and intentions. My own experience has been that a gentle, noticeable shift in awareness is desirable and what allows meaningful change to unfold.
Because readers often ask what a microdose actually feels like, I’ll describe my own experience. This isn’t presented as a universal experience or a recommendation, but as one example of how a microdose can unfold.
The microdoses I prepare for myself in Colorado, in accordance with state and local law, generally contain about 0.2 grams of dried, powdered Psilocybe mexicana or Psilocybe natalensis mushrooms, along with roughly equal amounts of several supportive compounds. My current favorites include Lion’s Mane, L-theanine, and ashwagandha.
I usually dose early in the morning before eating, which for me seems to make the experience more noticeable. Within thirty to forty minutes I begin to feel an overall lightness, almost as though a weight is slowly lifting from my body. That’s generally when I’ll spend thirty minutes meditating, which is why I’ve come to think of my own microdoses as Meditation Doses rather than simply microdoses.
One of the things I’ve noticed over the years is that difficult emotions often announce themselves first through the body. Anxiety settles in my stomach. Anger often appears as tightness in my throat. Confusion seems to collect in my head. That’s certainly not a universal rule, but it happens consistently enough that I’ve learned to pay close attention whenever a sensation appears.
When that happens, I try to become curious rather than reactive. I imagine myself as a kind friend—or perhaps a parent—sitting quietly beside a child who is trying to explain something important.
Stepping Outside the Aquarium
I often describe this as stepping outside the aquarium.
When we’re overwhelmed by emotion, it’s easy to feel trapped inside it, like a fish swimming endlessly around the same glass walls. The metaphor comes from an old companion of mine, Phish, a spirited Plecostomus catfish who lets me know every morning, in no uncertain terms, that he’s hungry. I can observe him, understand what he needs, and respond—but only when I am outside the aquarium. If I were inside the tank with him, I’d be just as trapped as he is.
Our emotions can be much the same. When we become completely identified with them, it’s difficult to understand what they’re trying to tell us. But when we step outside the aquarium, we create just enough distance to notice them with curiosity instead of becoming consumed by them.
For me, microdosing—combined with presence and deliberate attention—helps create that space. I’m often able to recognize not only what I’m feeling, but why I’m feeling it and, just as importantly, what that feeling may be asking of me. If there’s something I can do, I try to do it. If there isn’t, I practice letting it go.
Over the next hour or two I usually continue to notice a sense of physical lightness along with a subtle increase in visual clarity. Once a difficult emotion has been acknowledged and processed, I often return to a feeling of centeredness and well-being. If another emotion emerges, it almost always does so within the first few hours after dosing.
Over time, this has led me to an interesting conclusion. I don’t think microdosing magically makes me more creative, productive, or confident. Rather, I think it helps me notice and process the emotional material that was quietly consuming my attention in the background. As that emotional weight begins to lift, creativity, confidence, and productivity often seem to return on their own.
Perhaps those qualities weren’t missing after all.
Perhaps they were simply waiting behind the dam.
That realization has fundamentally changed the way I think about microdosing. Rather than seeing it as something that happens to me, I’ve come to see it as an active rather than passive practice. The medicine may open a window, but it’s my responsibility to decide what I do with that opportunity.
For that reason, I try to use the first few hours after a dose for intentional reflection, meditation, journaling, or whatever form of self-exploration feels most meaningful. I don’t simply wait for the medicine to do the work on its own. Instead, I see those first few hours as an invitation to meet myself with curiosity, honesty, and compassion.
A Note About Placebo
One of the most common misunderstandings in discussions about microdosing is that placebo and personal experience are somehow competing explanations. They’re not.
The well-known self-blinding citizen science study led by Balázs Szigeti found improvements in both the microdosing and placebo groups, with no significant differences between them after accounting for the study’s design. A more recent rapid review by Vince Polito and Paul Liknaitzky looked across the growing body of placebo-controlled microdosing studies and reached a more nuanced conclusion.
While expectancy clearly influences outcomes, the current evidence doesn’t support reducing every reported benefit to “just placebo.” Instead, the authors argue that the research remains too limited—and the studies too varied in their methods, doses, and populations—to draw such a simple conclusion.
How to use this Field Guide
Sections are arranged around the popular questions clients ask: personal safety, medication uncertainty, dosing specs, practices supporting microdosing, community protocols, and long-term evidence.
- Microdosing 101 overview — definitions, evidence types, and the limits of current knowledge.
- Safety and suitability — health contexts that call for particular caution.
- SSRIs, medications, and interactions — attenuation, uncertainty, and why medication changes are not a do-it-yourself protocol.
- Dosage and observing effects — research ranges, mushroom variability, product forms, impairment, and tracking.
- Supportive practices — reflection and routine without claims that they amplify a drug effect.
- Common microdosing protocols — community-developed patterns and their evidence limits.
- Long-term questions and evidence — mood, cognition, tolerance, reliance, neuroplasticity, and open safety questions.
Printable companion
Read online; reflect offline
A PDF version of this guide is available for printing or offline use.
How do I know if it’s working?
Many people begin microdosing hoping for a rapid shift in mood or emotional well-being. Sometimes those changes do happen, but in my experience they’re often subtle at first and tend to unfold over time. Even when an immediate shift is noticeable, it rarely lasts on its own without some intentional practice, whether that’s journaling, meditation, or another form of self-reflection.
For that reason, rather than asking, “Do I feel different today?” I encourage people to sit with a different question over days, weeks, and months:
“What am I noticing now that I wasn’t noticing before?”
My own belief is that microdosing doesn’t create entirely new emotions. More often, it gives us access to emotions that were already there, waiting to be noticed. The practice makes that noticing a little easier.
What we do with that awareness matters just as much as the dose itself. Lasting change comes not only from what the medicine reveals, but from our willingness to meet it with curiosity.
Be Prepared for Whatever Arises
One of the things I’ve learned is that we don’t always get to choose which emotions become available during these reflections.
I’ve watched people living with depression for decades suddenly experience an unexpected sense of wellbeing that’s eluded them for years after dosing for the first time. In contrast, some clients begin crying without knowing why as months of unprocessed grief finally found room to emerge.
Neither experience is necessarily better than the other. Both can be invitations to pay attention. And there’s generally no way to know what might come up.
After a dose, give yourself time
For that reason, I recommend dosing when you have a few unhurried hours in front of you and as few immediate responsibilities as possible, particularly during your first few weeks. If difficult emotions arise, give yourself permission to stay with them rather than rushing to make them disappear. Sometimes simply allowing those feelings to fully emerge and speak their peace is when the changes we’re chasing emerge on their own.
Sources and Further Reading
-
Psychedelic microdosing: A systematic review of research on benefits, risks, and methodological challenges
Systematic review
Polito and Liknaitzky, Neuroscience & Biobehavioral Reviews, 2022. Maps inconsistent definitions, methods, findings, and limitations across the early microdosing literature.
-
Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study
Controlled trial
Cavanna and colleagues, Translational Psychiatry, 2022. Examined 0.5 g of dried mushrooms in 34 participants and found noticeable acute effects without evidence for enhanced well-being, creativity, or cognition under its design.
-
Self-blinding citizen science to explore psychedelic microdosing
Placebo-controlled citizen science
Szigeti and colleagues, eLife, 2021. Found improvements in both microdose and placebo groups, illustrating how expectation and unblinding can shape results.
-
Is microdosing a placebo? A rapid review of low-dose LSD and psilocybin research
Rapid review
Polito and Liknaitzky, Journal of Psychopharmacology, 2024. Concludes that current evidence does not yet justify treating every reported microdosing effect as either pharmacological or purely placebo-driven.
-
Psilocybin for Mental Health and Addiction: What You Need To Know
U.S. health agency
National Center for Complementary and Integrative Health, reviewed 2026. Summarizes current safety concerns, adverse effects, evidence limits, and research gaps.
-
Psilocybin Drug Fact Sheet
U.S. government
Drug Enforcement Administration, current page reviewed July 24, 2026. Provides federal scheduling and basic substance information; state and local rules can differ.